From- Fondazione Per La Ricerca Ospedale Di Bergamo- Ets

This study follows 36 Italian adults with polycythemia vera, a blood cancer that causes too many red blood cells. All participants had a good response to the drug Ropeginterferon alfa-2b in an earlier trial and continue taking it. Researchers will check every 6 months whether the…

This study aims to find out how many people with hepatitis B also have hepatitis delta, a more serious liver infection. Researchers will test 244 adults in hospitals, addiction clinics, and prisons in Bergamo, Italy, using a new method introduced in 2025. The goal is to get a cle…

This study is testing a mobile app called ePro-Diary HDV to help people with hepatitis Delta (HDV) manage their condition. The app lets patients track lab results, answer quality-of-life questions, and communicate with their doctors. The goal is to see if using the app helps pati…

This study looks at people with a blood condition called essential thrombocythemia (ET) who later develop polycythemia vera (PV), a related disorder. Researchers want to find out what factors cause this change and whether these patients have different outcomes than those diagnose…

This study is testing a digital tool to help young people (ages 14-20) who have had or are waiting for a liver transplant as they move from pediatric to adult medical care. The tool is designed to help patients and their families manage treatment remotely and improve medication a…

This study is not testing a new treatment. Instead, it will follow about 617 adults diagnosed with myelofibrosis (a rare bone marrow cancer) across Europe. Researchers will collect information from medical records to understand how the disease progresses and how patients respond …